Showcasts: Page 3

BrightInsight launches digital diagnostics platform at AACC
By LabPulse.com staff writers
The platform consists of four tools -- Proxy Agent, Analytics Dashboards, Integration Middleware, and Workflow Portals -- for the IVD manufacturer and the lab, providing an end-to-end platform that streamlines workflows, according to BrightInsight.
July 24, 2022
2022 07 25 17 54 5379 Globe Digital 400
DiaSorin nabs FDA clearance for infectious disease blood test
By LabPulse.com staff writers
The fully automated test utilizes host response-based data to enable physicians to differentiate accurately between bacterial and viral infections, supporting faster and better-informed treatment and patient management decisions, DiaSorin said.
July 21, 2022
2020 08 27 17 11 6347 Infectious Diseases Research 400
Companies announce new products ahead of AACC 2022
By LabPulse.com staff writers
Among them, OraSure Technologies said that its Omnigene Gut DNA and RNA product is available to gut microbiome researchers. The product, made by OraSure subsidiary DNA Genotek, allows for self-collection, stabilization, storage, and transportation of both microbial DNA and RNA at ambient temperature for gut microbiome profiling.
July 21, 2022
2021 09 27 17 08 8174 Diagnostic Analyzer Lab Pcr 400
AACC sees rise in impact of medical laboratory journal
By LabPulse.com staff writers
The impact factor places it in the top 2% of 21,430 ranked academic journals and reaffirms that it is the top journal on medical laboratory technology, AACC said.
July 20, 2022
2021 09 27 17 08 8174 Diagnostic Analyzer Lab Pcr 400
Survey finds low morale among lab professionals
By LabPulse.com staff writers
The survey results show an industry struggling to replace retiring lab professionals at a sustainable rate while facing challenges created by the recent pandemic, Lighthouse said in a statement.
July 20, 2022
2022 01 26 06 58 5027 Women Laboratory 400
Beckman, Scopio to partner on blood smear platforms
By LabPulse.com staff writers
Scopio's technology employs full-field imaging and artificial intelligence (AI) decision support with the aim of eliminating manual microscopy. The platform allows full-field images to be shared in real-time over a secure hospital network and captures large scan areas at 100X magnification.
July 19, 2022
2020 03 25 23 27 0591 Hands Shaking Deal 400
How has the COVID-19 pandemic affected pediatric care?
Elhadi, an assistant professor of health, behavior, and policy at the university discussed his research on the impact of the COVID-19 pandemic on pediatric cancer patients with LabPulse.com at the recent American Association for Cancer Research (AACR) meeting in New Orleans.
May 2, 2022
2022 05 03 19 56 4723 2022 05 03 Elhadi Aacr 400
New task force promotes pathology for cancer research
By LabPulse.com staff writers
Efforts of the task force include an award program for outstanding pathology research in cancer, knowledge hubs on pathology for medical students, and the development and adoption of new technologies in pathology. Parwani shed light on the new task force in an interview with LabPulse at the recent American Association for Cancer Research (AACR) meeting in New Orleans.
May 2, 2022
2022 05 03 13 14 8568 2022 05 02 Aacr Parwani 400
CoVac-1 vaccine shows promise for immunocompromised patients
Walz's team used their expertise with cancer therapeutics to develop a vaccine that induces T cells in immunocompromised patients who do not produce an adequate immune response to other vaccines.
May 1, 2022
2022 04 29 20 08 5415 2022 04 29 Aacr Tandler Walz 400
AACR 2022 video: DCIS lesions may affect treatment
In the study, Kader et al found that patients with recurrent DCIS lesions that are genetically distinct from the primary tumor may require different treatment.
April 12, 2022
2022 04 13 20 41 6411 Kader Thumbnail 400
Guardant highlights data on multicancer test at AACR 2022
By LabPulse.com staff writers
Guardant Shield analyzes about 20,000 epigenomic markers with a single blood test. In the data presented at AACR 2022, researchers showed the efficacy of Guardant Shield in the detection of four types of early-stage cancers: colorectal, lung, pancreatic, and bladder.
April 12, 2022
2017 09 14 23 05 1167 Cancer Cell 400
AACR 2022: Project GENIE spurs sharing of real-world data
GENIE, which stands for Genomics Evidence Neoplasia Information Exchange, is a publicly accessible international cancer registry of real-world data assembled by the AACR through data sharing between 19 of the leading cancer centers in the world.
April 11, 2022
2022 04 12 20 37 1672 Sweeney Thumbnail 400
Previous Page
Page 3 of 6
Next Page